Successful commercialization of promising emerging technology requires risk mitigation in the development of marketing strategy. A Strategy Inc. Risk Analysis identifies the specific strengths, weaknesses, opportunities and threats in all areas of medical device development and commercialization including:

• Technology
• Clinical
• Market acceptance
• Competition
• Regulatory
• Financial

This comprehensive analysis provides the needed blue print for success.